2 results
Approved WMOPending
To show differences in uptake of Primovist between FNHs and hepatocellular adenomas on CT.
Approved WMORecruiting
To evaluate whether a faecal calprotectin guided strategy of anti-TNF dosing interval lengthening is non-inferior in maintaining remission in patients with IBD compared with an unchanged dosing interval.